Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mirum Pharmaceuticals Q3 EPS $0.05 Beats $(0.14) Estimate, Sales $133.010M Beat $130.074M Estimate

Author: Benzinga Newsdesk | November 04, 2025 04:02pm
Mirum Pharmaceuticals (NASDAQ:MIRM) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.14) by 135.97 percent. This is a 116.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $133.010 million which beat the analyst consensus estimate of $130.074 million by 2.26 percent. This is a 47.17 percent increase over sales of $90.377 million the same period last year.

Posted In: MIRM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist